company background image
BIIO logo

Bionovate Technologies OTCPK:BIIO Stock Report

Last Price

US$0.0001

Market Cap

US$775.0

7D

0%

1Y

0%

Updated

26 Mar, 2024

Data

Company Financials

Bionovate Technologies Corp

OTCPK:BIIO Stock Report

Market Cap: US$775.0

BIIO Stock Overview

Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots.

BIIO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Bionovate Technologies Corp Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bionovate Technologies
Historical stock prices
Current Share PriceUS$0.0001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Change9,900.00%
1 Year Change0%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

BIIOUS Medical EquipmentUS Market
7D0%2.2%0.4%
1Y0%13.3%28.8%

Return vs Industry: BIIO underperformed the US Medical Equipment industry which returned 10.6% over the past year.

Return vs Market: BIIO underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is BIIO's price volatile compared to industry and market?
BIIO volatility
BIIO Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: BIIO's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine BIIO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aTimothy Joneshttps://bionovate.com

Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide.

Bionovate Technologies Corp Fundamentals Summary

How do Bionovate Technologies's earnings and revenue compare to its market cap?
BIIO fundamental statistics
Market capUS$775.00
Earnings (TTM)-US$105.31k
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIIO income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$105.31k
Earnings-US$105.31k

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did BIIO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.